Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach

Area of Science:

• Oncology
• Biochemistry
• Medical Chemistry

Background:

• Breast cancer is a leading global cancer diagnosis, necessitating novel therapeutic strategies beyond conventional treatments.
• Cancer cell proliferation is critically dependent on iron availability.
• Excess iron and disrupted iron metabolism contribute to breast carcinogenesis via reactive oxygen species (ROS) generation.

Purpose of the Study:

• To review the potential of iron chelators as a therapeutic strategy for breast cancer.
• To explore how iron depletion impacts cancer cell proliferation, DNA synthesis, and apoptosis.
• To evaluate the hypothesis that iron chelators can inhibit breast tumor growth.

Main Methods:

• Literature review focusing on the role of iron in breast cancer.
• Analysis of iron metabolism pathways and their link to carcinogenesis.
• Examination of iron chelator mechanisms in depleting tumor iron levels.

Main Results:

• Iron chelators can reduce intracellular iron concentrations in breast cancer cells.
• Depletion of iron inhibits free radical generation and DNA synthesis.
• Reduced iron availability promotes cancer cell apoptosis.

Conclusions:

• Iron chelators represent a promising therapeutic avenue for breast cancer treatment.
• By controlling intracellular iron, chelators can inhibit tumor growth and reduce patient morbidity.
• Targeting iron metabolism offers a novel strategy to enhance breast cancer therapy.